Thrombophilia
Recent clinical, regulatory, research and industry developments relating to this disease.
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes2
- Betacoronavirus1
- Pandemics1
Leading journals1
- Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis1
Leading researchers2
- Makris M1
- Miesbach W1
Affiliations (unnormalised)3
- Department of Haemostaseology and Hemophilia Center1
- Sheffield Haemophilia and Thrombosis Centre1
- University of Sheffield1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.